Annual report
7634.TEDINET S100OMK1
Period2021-04-01 → 2022-03-31
Filed2022-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥11.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥10.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥994m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥735m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥871m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥862m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥20.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥19.0bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥17.4bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥16.8bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥16.1bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.5bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.5bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥12.6bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.0bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.4bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.4bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥7.8bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.5bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥690m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥64m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥754m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥385m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥937m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥882m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥676m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥637m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥358.33 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥313.14 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥224.88 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥263.58 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥261.12 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥4,594.54 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,289.53 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,933.55 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,769.15 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,562.02 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.0% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.2% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 439 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 431 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 418 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 407 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 393 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥10.9bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥10.2bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥9.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥990m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.3bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥971m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥890m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥681m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥815m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥797m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥18.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥17.2bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥15.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.2bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.6bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.3bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥12.8bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.9bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.6bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥11.3bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥10.7bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.4bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥314.16 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.41 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.51 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥246.81 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.33 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥55 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥4,123.08 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,855.53 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,565.5 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,426.84 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,239.67 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.3% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.8% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,420,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,601,681 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 313 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 305 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 288 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 289 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 276 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 104
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥388,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥63m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥170m |
| Care Welfare Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥18m |
| Care Welfare Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥11m |
| Care Welfare Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥936m |
| Care Welfare Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥936m |
| Care Welfare Relatedreportable segment | segment assets | at 2022-03-31 | ¥336m |
| Care Welfare Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥71m |
| Home Medical Treatment Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥941m |
| Home Medical Treatment Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥710m |
| Home Medical Treatment Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.5bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.5bn |
| Home Medical Treatment Relatedreportable segment | segment assets | at 2022-03-31 | ¥2.5bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥580m |
| Medical Gas Equipment Installation Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥17m |
| Medical Gas Equipment Installation Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥84m |
| Medical Gas Equipment Installation Relatedreportable segment | segment assets | at 2022-03-31 | ¥264m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥196m |
| Medical Gas Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥167m |
| Medical Gas Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥96m |
| Medical Gas Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Medical Gas Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Medical Gas Relatedreportable segment | segment assets | at 2022-03-31 | ¥1.4bn |
| Medical Gas Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥569m |
| Nursing Homereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥235,000 |
| Nursing Homereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥20m |
| Nursing Homereportable segment | employees | at 2022-03-31 | 14 pure |
| Nursing Homereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥360m |
| Nursing Homereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥360m |
| Nursing Homereportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Nursing Homereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥10m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥839m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥11.5bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥11.4bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥84m |
| —segment total | segment assets | at 2022-03-31 | ¥5.8bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥840m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥12.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥84m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2020-04-01 → 2021-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥421,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-03-31 | ¥62m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥160m |
| Care Welfare Relatedreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥7m |
| Care Welfare Relatedreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥11m |
| Care Welfare Relatedreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥834m |
| Care Welfare Relatedreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥834m |
| Care Welfare Relatedreportable segment | segment assets | at 2021-03-31 | ¥242m |
| Care Welfare Relatedreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥142m |
| Home Medical Treatment Relatedreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥838m |
| Home Medical Treatment Relatedreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥586m |
| Home Medical Treatment Relatedreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥4.9bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥4.9bn |
| Home Medical Treatment Relatedreportable segment | segment assets | at 2021-03-31 | ¥2.2bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥510m |
| Medical Gas Equipment Installation Relatedreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥10m |
| Medical Gas Equipment Installation Relatedreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥77m |
| Medical Gas Equipment Installation Relatedreportable segment | segment assets | at 2021-03-31 | ¥219m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥155m |
| Medical Gas Relatedreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥154m |
| Medical Gas Relatedreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥101m |
| Medical Gas Relatedreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥3.3bn |
| Medical Gas Relatedreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥3.3bn |
| Medical Gas Relatedreportable segment | segment assets | at 2021-03-31 | ¥1.3bn |
| Medical Gas Relatedreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥450m |
| Nursing Homereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3m |
| Nursing Homereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥20m |
| Nursing Homereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥369m |
| Nursing Homereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥369m |
| Nursing Homereportable segment | segment assets | at 2021-03-31 | ¥1.3bn |
| Nursing Homereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥24m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥1.0bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥720m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥10.7bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥10.6bn |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥77m |
| —segment total | segment assets | at 2021-03-31 | ¥5.2bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥720m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥77m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥5.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥1.4bn |
| Nursing Homereportable segment | employees | at 2022-03-31 | 14 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,527
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf | CurrentYearDuration | -571230000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YearDuration | 111440000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYearDuration | 5520000 | JPY |
| Payments for retirement of property plant and equipment inv cf | Prior1YearDuration | -7352000 | JPY |
| Payments for retirement of property plant and equipment inv cf | CurrentYearDuration | － | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration | -2594000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -86887000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -30668000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -26568000 | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | Prior1YearDuration | -20700000 | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | CurrentYearDuration | － | JPY |
| Proceeds from sales and redemption of investment securities inv cf | Prior1YearDuration | 107261000 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | CurrentYearDuration | － | JPY |
| Expenditure by the loan of the long term loan inv cf | Prior1YearDuration | -17000000 | JPY |
| Expenditure by the loan of the long term loan inv cf | CurrentYearDuration | -700000 | JPY |
| Collection of long term loans receivable inv cf | Prior1YearDuration | 1173000 | JPY |
| Collection of long term loans receivable inv cf | CurrentYearDuration | 1045000 | JPY |
| Other payments inv cf | Prior1YearDuration | -12249000 | JPY |
| Other payments inv cf | CurrentYearDuration | -12808000 | JPY |
| Other proceeds inv cf | Prior1YearDuration | 462000 | JPY |
| Other proceeds inv cf | CurrentYearDuration | 1366000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -64142000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -690264000 | JPY |
| Repayments of lease obligations fin cf | Prior1YearDuration | -628449000 | JPY |
| Repayments of lease obligations fin cf | CurrentYearDuration | -783059000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -649924000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -336000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -162244000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -153503000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -1440618000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -936899000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 974880000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 347543000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 7397834000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 8372714000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 8372714000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 8720258000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 5 | |
| Notes receivable trade | CurrentYearInstant | 292516000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 2220727000 | JPY |
| Contract assets | CurrentYearInstant | 25016000 | JPY |
| Contract liabilities | CurrentYearInstant | 169220000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 23566000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 50200000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E03330-000MedicalGasRelatedReportableSegmentsMember | 3265465000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E03330-000HomeMedicalTreatmentRelatedReportableSegmentsMember | 4903564000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E03330-000MedicalGasEquipmentInstallationRelatedReportableSegmentsMember | 1226648000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E03330-000CareWelfareRelatedReportableSegmentsMember | 834285000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E03330-000NursingHomeReportableSegmentsMember | 368520000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 10598484000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |